Navigation Links
Lixte Biotechnology Holdings Announces Issuance of U.S. Patent for Agents for the Treatment of Neurodegenerative Diseases
Date:1/9/2012

EAST SETAUKET, N.Y., Jan. 9, 2012 /PRNewswire/ -- Lixte Biotechnology Holdings (OTC: LIXT.PK) announces that the United States Patent and Trademark Office awarded a patent for the use of lead compounds from each of two different types of drugs, protein phosphatase inhibitors and histone deacetylase inhibitors, for the potential prevention and treatment of neurodegenerative diseases.

Dr. John S. Kovach, founder and president of Lixte, said, "We have developed a series of novel compounds primarily as potential treatments for several common cancers as well as brain tumors of adults and children.  Some of these compounds, however, have been shown in laboratory studies to affect the biochemical status of human brain cells in ways believed to be beneficial to normal cell function and, unlike most potent anti-cancer drugs, appear to have tolerable toxicity in animals even when given for many days. We are looking to develop these compounds as neuroprotective agents of potential relevance to the prevention and treatment of a broad spectrum of neurodegenerative diseases, including acute neurological injury and chronic conditions such as Alzheimer's disease and Parkinson's disease.  Because Lixte is predominantly focused on developing anti-cancer drugs, we are interested in exploring licensing and/or partnerships for development of our lead compounds with companies having major programs in prevention and treatment of neurological illnesses."

About Lixte Biotechnology Holdings, Inc.

Lixte is a cancer drug discovery company, using biomarker technology and innovative chemistry to develop new potentially more effective anti-cancer drugs. It has lead compounds in two classes of drugs, protein phosphatase inhibitors for which a US patent was recently issued with world-wide patent applications pending for its lead compound LB-100 and structural variants , and novel histone deacetylase inhibitors for which broad patent applications are also pending.
'/>"/>

SOURCE Lixte Biotechnology Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Lixte Biotechnology Holdings Compound LB-205 Reported to Have Therapeutic Potential for Gaucher Disease
2. Lixte Biotechnology Holdings, Inc. Awarded Grant Under Qualifying Therapeutic Discovery Project from the U. S. Government
3. Lixte Biotechnology Holdings, Inc. Announces the Approval of a Collaboration with the National Cancer Institute for Clinical Evaluation of its Lead Anti-Cancer Compound, LB-100.
4. Lixte Biotechnology Holdings Announces Filing of a New Patent Application for the Use of Novel Compounds as Potential Treatment for Neurodegenerative Diseases
5. Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer
6. Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research
7. Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement
8. Goodwin Biotechnology and OncoMax, a Maxwell Biotech Portfolio Company, Announce a "Bench-to-Clinic" Collaboration for an Important Advance in Oncology
9. Medical Marijuana Inc. to Acquire Biotechnology Company PharmaSphere, LLC from Converted Organics
10. Active Pharmaceutical Ingredients (APIs) in the Americas Market to 2016 - Growth in Biotechnology and Generic Segments and the Pharmaceutical Patent Cliff will Shape the Landscape
11. Goodwin Biotechnology Announces a Collaboration with Spectros Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... June 19, 2013  Decision Resources, one of ... pharmaceutical and healthcare issues, finds that, for the ... U.S. and European rheumatologists cite a therapy,s induction ... most influences their prescribing decisions. Over 60 percent ... respectively, rank the percentage of patients achieving remission ...
(Date:6/19/2013)... -- BD Biosciences, a segment of BD (Becton, Dickinson and ... technology company, today announced the launch of the BD ... of high-performance research flow cytometers. The BD ... most compact footprint in its class at just 30" x ... (76.2 cm). Recognizing that space is a valuable commodity in ...
(Date:6/19/2013)... N.J. , June 19, 2013 /PRNewswire-iReach/ ... Pharma, a new specialty pharmaceutical company dedicated ... of innovative injectable and sustained release drug ... unmet medical needs, today announced the acquisition ... Linker Technology®) platform and associated product pipeline. ...
Breaking Medicine Technology:U.S. and European Rheumatologists Agree That a Therapy's Induction of Remission is One of the Attributes That Most Influences Their Prescribing Decisions in Rheumatoid Arthritis 2New BD Biosciences Flow Cytometry Cell Analyzer Enables Complex Multicolor Experiments in Disease Research 2Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 2Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 3Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 4
... TARPON SPRINGS, Fla., May 7 Methadone medication ... to menopausal levels, even in women less than ... methadone, can cause depression, anxiety, fatigue, weight gain, ... flashes, and increased risk for heart attack and ...
... May 7 In letters to Senate Special Committee ... Committee Ranking Member Charles Grassley (R-IA), Johnson & Johnson ... Act of 2009 (S. 301). The company also committed ... its U.S. pharmaceutical, medical device and diagnostics companies."We are ...
Cached Medicine Technology:Methadone Frequently Causes Menopausal Symptoms in Young Women 2Johnson & Johnson Announces Support for Kohl-Grassley Physician Payments Sunshine Act of 2009 2Johnson & Johnson Announces Support for Kohl-Grassley Physician Payments Sunshine Act of 2009 3
(Date:6/19/2013)... Go Classy Tours has the reputation for specializing in ... Years. These resorts, draw many clients from around the ... nude hot tubs. Grand Lido Negril was a favorite ... the resort to a Breezes and dis-continued the "Lido" luxury ... fell off dramatically. "Groups just went to other nude ...
(Date:6/19/2013)... June 19, 2013 According to ... clinics, excessive sun exposure is perhaps the biggest ... cancer, but that is just one of many ... of skin cancer. Other risk factors include:, ...     Radiation treatment ,     Heredity may play a ...
(Date:6/19/2013)... Scottsdale, AZ (PRWEB) June 19, 2013 Are ... could be losing clients to the competition. , Social ... sales at your massage practice. , Included in your ... into an effective tool in building awareness and revenue for ... now over 5.5 million Twitter users worldwide. Many of these ...
(Date:6/19/2013)... PrettySkin4Less announces it is stocking up ... by top skin care manufacturer EMINENCE to meet customer ... minerals and active organic ingredients to promote actual change ... beauty products offer. For this reason it’s not hard ... "I like products that do what they say they ...
(Date:6/19/2013)... Sylmar, CA (PRWEB) June 19, 2013 ... to its website located at http://www.kleritec.com . In ... and creative, pre-selected, art and activities packages for pre-school ... educational products as a method to aid teachers across ... busy and engaged in learning. , Included in the ...
Breaking Medicine News(10 mins):Health News:The Former Breezes Resort is Re-Opened by Blue Diamond Resorts as the Original Grand Lido Negril Announced Go Classy Tours 2Health News:Risk Factors of Skin Cancer & Reducing That Risk 2Health News:Risk Factors of Skin Cancer & Reducing That Risk 3Health News:If Your Massage Practice Isn’t Tweeting, It Isn’t Generating New Sales: 3 Ways Twitter Helps Grow Massage Practices from Appointment-Plus 2Health News:PrettySkin4Less Launches New Innovative Skin Serums with Active Organic Ingredients to World Wide Consumer Base 2Health News:Kleritec Announces Addition of Educational Products. 2
... , , FRIENDSWOOD, Texas, ... which develops, manages and owns faith-based senior living facilities, today announced ... Inc. for the development of a new senior living facility in ... Heights , an 82-unit, $10 million senior living facility, should be ...
... , COLORADO SPRINGS, Colo., July 28 University ... Military Tuition Grant for university students serving on active duty in ... National Guard and reserves, who pursue a master,s or doctoral degree ... Active Duty Military Tuition Grant offers the following benefits, effective with ...
... , , SAN DIEGO, ... San Diego based medical device company, today announced that F. ... its Board of Directors. , , ... following graduation from San Diego State University in 1961. He ...
... , BATON ROUGE, La. and ALEXANDRIA, Va., ... Rx Access announced today the launch of the Together Rx Access(R) ... immediate and meaningful savings on prescription medicines and products right at ... collaboration will use existing State outreach channels to identify additional uninsured ...
... , BEDFORD, Mass., July 28 ... (Nasdaq: HOLX ), a leading developer, manufacturer and ... dedicated to serving the healthcare needs of women, today announced ... for women suffering from excessive menstrual bleeding--has passed the one ...
... , , , ... (pronounced ah-sigh-EE) has become America,s new super fruit of choice due ... of acai juice can contain a large amount of natural sugar, ... Healthy Balance line of Fit for Your Lifestyle(TM) ...
Cached Medicine News:Health News:TrinityCare Senior Living Announces Funding Agreement for Fifth Senior Living Facility 2Health News:TrinityCare Senior Living Announces Funding Agreement for Fifth Senior Living Facility 3Health News:TrinityCare Senior Living Announces Funding Agreement for Fifth Senior Living Facility 4Health News:University of the Rockies Introduces Military Tuition Grant 2Health News:F. Duwaine Townsen Joins SpectraScience Board of Directors 2Health News:F. Duwaine Townsen Joins SpectraScience Board of Directors 3Health News:F. Duwaine Townsen Joins SpectraScience Board of Directors 4Health News:The State of Louisiana and Together Rx Access Join Forces to Improve Prescription Access for Uninsured Residents 2Health News:The State of Louisiana and Together Rx Access Join Forces to Improve Prescription Access for Uninsured Residents 3Health News:The State of Louisiana and Together Rx Access Join Forces to Improve Prescription Access for Uninsured Residents 4Health News:Photos: One Million Patients Choose Hologic's NovaSure(R) System Over Hysterectomy 2Health News:Photos: One Million Patients Choose Hologic's NovaSure(R) System Over Hysterectomy 3Health News:Photos: One Million Patients Choose Hologic's NovaSure(R) System Over Hysterectomy 4Health News:Photos: One Million Patients Choose Hologic's NovaSure(R) System Over Hysterectomy 5Health News:Old Orchard Brands Introduces Low-Sugar Acai Juice Blend 2
... thermocycler with unique High Temperature ... fastest available heating and cooling ... High Pressure Lid for automated ... Includes motorized lid for automated ...
... TC-512 has a graphical touch screen display ... at the "touch of a screen." ... gradient, Touch Screen, Graphical Display, Memory Cards, ... Block Format, Intuitive Programmin, Free Instrument Software ...
... 32 Thermal Block has a compact design for ... temperatures rapidly, and can handle up to 32 samples ... so there is no need to add mineral oil ... 100 programs can be stored, and up to 15 ...
PTC-100 cycler with Hot Bonnet heated lid,holds sixty 0.5ml tubes...
Medicine Products: